FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Nutriband's Free Cash Flow for the
three
months ended in Apr. 2026 was $-0.56 Mil. Nutriband's Revenue for the
three
months ended in Apr. 2026 was $0.43 Mil. Therefore, Nutriband's FCF Margin % for the quarter that ended in Apr. 2026 was -130.02%.
The historical rank and industry rank for Nutriband's FCF Margin % or its related term are showing as below:
NTRB'
s FCF Margin % Range Over the Past 10 Years
Min: -452.65 Med: -211.91 Max: -31.46
Current: -241.95
During the past 11 years, the highest FCF Margin % of Nutriband was -31.46%. The lowest was -452.65%. And the median was -211.91%.
NTRB's FCF Margin % is ranked worse than 62.57% of 959
companies
in the Biotechnology industry
Industry Median: -84.65
vs NTRB: -241.95
Nutriband FCF Margin % Related Terms
Nutriband FCF Margin % Historical Data
* Premium members only.
The historical data trend for Nutriband's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Nutriband's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nutriband FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nutriband's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Nutriband's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nutriband (NTRB) has a FCF Margin % of -130.02% as of Apr. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Nutriband and its competitors. According to the industry distribution chart, Nutriband ranks #600 out of 959 companies in the Biotechnology industry, placing it in the top 62.6%.
Is Nutriband's FCF Margin % too high?
Nutriband's current FCF Margin % is -130.02%. Based on the distribution chart, Nutriband ranks #600 out of 959 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Nutriband has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nutriband's FCF Margin % compare to KALA and RNXT?
According to the Biotechnology industry distribution chart, Nutriband ranks #600 out of 959 companies for FCF Margin %. This places Nutriband in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Nutriband and its competitors. Nutriband's current FCF Margin % is -130.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutriband stock overvalued right now?
Based on GuruFocus' analysis, Nutriband (NTRB) is currently considered Fairly Valued. The stock's GF Value™ is $3.25, compared to a current price of $3.01 — trading 7.4% below its estimated fair value. The current FCF Margin % is -130.02%. Nutriband's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Nutriband (NTRB), the current FCF Margin % is -130.02% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nutriband (NTRB) Overvalued in 2026?
Based on GuruFocus' analysis, Nutriband stock appears to be undervalued.
The current stock price of $3.01 is trading 7.4% below its estimated GF Value™ of $3.25.
GuruFocus considers Nutriband to be Fairly Valued.
Key valuation signals for NTRB:
FCF Margin %: -130.02%
GF Value™: $3.25 vs. price of $3.01 (7.4% below fair value)
No single metric tells the full story. See the NTRB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
61GF Score
Get the complete analysis for NTRB
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NTRB has been successfully added to your 
